Stockscreener 앱 받기
2.9299
0.34%
-0.0101
전일 마감가:
$2.94
열려 있는:
$2.88
하루 거래량:
21,071
Relative Volume:
0.01
시가총액:
$3.55M
수익:
-
순이익/손실:
$-4.74M
주가수익비율:
-3.9065
EPS:
-0.75
순현금흐름:
$-3.46M
1주 성능:
-6.69%
1개월 성능:
+8.51%
6개월 성능:
-16.16%
1년 성능:
-64.44%
1일 변동 폭
$2.87
$2.9781
1주일 범위
$2.82
$3.48
52주 변동 폭
$2.21
$12.00
Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile
명칭
Lipella Pharmaceuticals Inc
전화
412-901-0315
주소
400 N LEXINGTON ST, PITTSBURGH
LIPO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIPO
Lipella Pharmaceuticals Inc
|
2.9299 | 3.55M | 0 | -4.74M | -3.46M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.62 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
695.25 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.43 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.83 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
269.72 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스
Lipella Pharmaceuticals modifies agreement with Spartan Capital By Investing.com - Investing.com South Africa
Lipella Pharmaceuticals modifies agreement with Spartan Capital - Investing.com
With New Data, Lipella Plots 2025 Milestones For Oral Rinse Tacrolimus - News & Insights
Analyzing Lipella Pharmaceuticals (NASDAQ:LIPO) and IDEAYA Biosciences (NASDAQ:IDYA) - Defense World
Lipella Pharmaceuticals Gains Buy Rating from Jason McCarthy Following Positive Phase 2a Results for LP-310 - TipRanks
3 Penny Stocks to Watch Now, 2/13/25 - TipRanks
Lipella Pharmaceuticals Announces Positive Phase 2a Results for LP-310 in Oral Lichen Planus Treatment - Defense World
Biotech Rips On Topline Analysis - The Globe and Mail
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus - GlobeNewswire
Lipella Pharmaceuticals Shares Rise After Positive Phase 2a Trial Results for Oral Lichen Planus Treatment - Marketscreener.com
Stock market news: Firefly Neuroscience +214.56%, Dominari Holdings +37.66% among top gainers during midday trading - Business Upturn
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes - Benzinga
Stock market today: Firefly Neuroscience +60.32%, Dominari Holdings +36.36% among top gainers in early trading - Business Upturn
Lipella Pharmaceuticals Gains FDA Approval for LP-310 - TipRanks
Lipella Pharmaceuticals (LIPO) Stock Soars In Pre-Hour Session - Stocks Telegraph
Clinical Trials News Live Feed - StockTitan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
How Did Markets React to the Latest Round of Tariff Announcements? - The Globe and Mail
Clinical Trial Success: Lipella's LP-310 Slashes Pain Scores by 64% in Oral Disease Study - StockTitan
Top Small Cap Stocks To Watch NowFebruary 06th - MarketBeat
Lipella Pharmaceuticals Inc (LIPO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Taking on analysts’ expectations and winning: Lipella Pharmaceuticals Inc (LIPO) - SETE News
FDA approves Lipella's oral treatment access program - MSN
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable
Analyzing the Price-to-Earnings Ratio of Lipella Pharmaceuticals Inc (LIPO) - The News Heater
🔬 Latest pharma industry updates 👇 - substack.com
Stock summary: Lipella Pharmaceuticals posted weekly surge of 13.70% as it got FDA approval for an expanded access program - Business Upturn
LIPO Stock Sees Surge of Approximately 74.16% in Last Five Days - Knox Daily
Is Lipella Pharmaceuticals Inc (NASDAQ:LIPO) stock a better investment at this time? - US Post News
Lipella Pharmaceuticals Receives Buy Rating Amidst Promising FDA Approval and Strategic Financial Moves - TipRanks
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Lipella Pharmaceuticals Inc [LIPO] Revenue clocked in at $0.48 million, up 52.46% YTD: What’s Next? - The DBT News
FDA approves Lipella’s oral treatment access program By Investing.com - Investing.com Nigeria
Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment - Mugglehead
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Offerings News Live Feed - StockTitan
Stock market news: Lipella Pharmaceuticals +96.90%, Digital Turbine +66.19% among top gainers as investors assess corporate earnings report - Business Upturn
Stock market news: Lottery.com surged by 93.55% while Lipella Pharmaceuticals posted rise of 86.44% during mid day trading - Business Upturn
Strong Earnings Drive Digital Turbine (APPS) Stock’s Market Rally - Stocks Telegraph
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook - Benzinga
Acquisition Announcement Propels Altus Power (AMPS) Shares Upward - Stocks Telegraph
Stock market today: Lipella Pharmaceuticals jumped by 98.06% whereas ReTo Eco-Solutions plunged by 38.75% in early trading - Business Upturn
Stock market today: Lipella Pharmaceuticals +99.22%, Digital Turbine +68.90% among top gainers in early trading - Business Upturn
Dow Edges Higher; US Weekly Jobless Claims Increase - Benzinga
FDA Greenlight Sends Lipella Pharma Stock Skyrocketing 160% - Wall Street Pit
Lipella Pharmaceuticals (LIPO) Stock Sees Strong Pre-Market Rally - Stocks Telegraph
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus - GlobeNewswire
Revolutionary Oral Disease Treatment Gets FDA Early Access Approval6M Americans Could Benefit - StockTitan
BigBear.ai (BBAI) Stock Gains Momentum After A Defense Deal - Stocks Telegraph
Lipella Pharmaceuticals Inc (LIPO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lipella Pharmaceuticals Inc 주식 (LIPO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kaufman Jonathan H | See remarks below. |
Mar 18 '24 |
Buy |
0.79 |
30,000 |
23,649 |
863,849 |
| Kaufman Jonathan H | See remarks below. |
Mar 19 '24 |
Buy |
0.87 |
25,000 |
21,802 |
888,849 |
1.73%
0.68%
자본화:
|
볼륨(24시간):